This page uses content from Wikipedia and is licensed under CC BY-SA.

3,4-Methylenedioxy-N-methoxyamphetamine

3,4-Methylenedioxy-N-methoxyamphetamine
MDMEO.png
Names
IUPAC name
1-(1,3-benzodioxol-5-yl)-N-methoxypropan-2-amine
Identifiers
3D model (JSmol)
ChemSpider
Properties
C11H15NO3
Molar mass 209.245 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☑Y verify (what is ☑Y☒N ?)
Infobox references

3,4-Methylenedioxy-N-methoxyamphetamine (MDMEO, MDMEOA, or MDMeOA) is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-methoxy analogue of MDA. MDMEO was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180 mg. MDMEO may be found as white crystals. It produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEO.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[1]

See also

References

  1. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.

External links